Anti-mitotic Drugs Current Events | Anti-mitotic Drugs News | 9
|
| Page
9 of
58 |
1150 Results |
|
|
|
Sort By:
Page Views | Date |
Study supports triple combination therapy for HIV
New evidence in this week’s BMJ supports the use of up to three antiviral drugs (triple therapy) to treat people with HIV. view more (2002-03-27)
Pricey new versions of old drugs fuelling huge rise in drug spending
Newly patented versions of old drugs are driving the rapid growth in expenditure on prescription drugs in most developed countries, without offering substantial improvements over existing products, finds a study published online by the BMJ today. view more (2005-09-02)
First results from novel anti-angiogenic drug trial in patients
"Surprisingly effective" says French research team Frankfurt, Germany: A new drug that targets tumour blood vessels has produced a surprisingly effective response in its first patient study - shrinking the tumours in a number of patients treated so far, according to researchers carrying out the study at the Institut Gustave Roussy in Villejuif,... view more... (2002-11-17)
Study provides hope that some transplant patients could live free of anti-rejection drugs
People with organ transplants, resigned to a lifetime of anti-rejection drugs, may now have reason to hope for a respite, say researchers at Lucile Packard Children's Hospital and the Stanford University School of Medicine. view more (2007-08-21)
Groundbreaking biomedical researchers receive £395,000
Internationally leading biomedical research at the University of Sussex involving the development of anti-cancer drugs and gene therapy applications has been boosted by a £395,519 grant. The funding from the Engineering and Physical Sciences Research Council (EPSRC) was made to chemistry professors Norman Billingham and Steven Armes, whose... view more... (2003-03-13)
Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found. view more (2006-12-14)
Is Bcl-2 protein a major obstacle in treating colorectal carcinoma?
Apoptosis resistance has been shown to contribute to the development of different cancer entities, such as colorectal carcinoma (CRC). view more (2008-09-24)
A new way of treating the flu
What happens if the next big influenza mutation proves resistant to the available anti-viral drugs? view more (2009-05-20)
First international guidelines for treatment of psoriatic arthritis
Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it. view more (2008-10-27)
Bisphosphonate drugs reduce the risk of broken bones in breast cancer patients
Bisphosphonate drugs reduce the risk of bone complications when used in patients whose cancer has spread to the bone, according to a new study in the BMJ. view more (2003-08-29)
Scientists use PET scans to monitor lung inflammation noninvasively
A noninvasive approach for assessing lung inflammation should accelerate efforts to develop drugs for inflammatory lung conditions like cystic fibrosis and pneumonia, scientists at Washington University School of Medicine in St. Louis report. view more (2006-03-09)
Microtubule protein interactions visualized en masse
In a new study published online in the open access journal PLoS Biology, Philipp Niethammer, Eric Karsenti, and colleagues investigate the regulation of microtubule dynamics via application of their new method, called visual immunoprecipitation (VIP), which enables simultaneous visualization of multiple protein interactions in cell extracts. view more (2007-01-16)
Study shows blood markers can help choose best dose for antiangiogenic drugs
Scientists at Sunnybrook have new information that may help to improve the use of anti-cancer drugs designed to block the growth of new blood vessels in tumors, a process called angiogenesis that is critical to tumor growth. view more (2007-10-26)
What is the influence of tumor removal on the serum level of carbohydrate's antibody?
Cancer immune surveillance is considered to be important in the anti-tumor protection of the host. The growing tumor escapes the immune control under the immunosuppressive conditions. view more (2008-10-08)
Serendipity versus planning-cancer drugs of the future?
Delegates at the European Breast Cancer Conference (EBCC-5) were given two examples of promising new drugs to watch in the future-raloxifene and lapatinib. view more (2006-03-27)
The anti-consumption movement: Researchers examine resistance to global brands
What motivates people to rebel against global brands-or consumption in general? A new study in the Journal of Consumer Research examines the connection between nationalism and the anti-consumption movement in India. view more (2009-06-16)
Treating depression in pregnancy
A new report from the American Psychiatric Association (APA) and the American College of Obstetricians and Gynecologists, which is published by Elsevier in the September-October 2009 issue of General Hospital Psychiatry, explores the management of pregnancy and depression. view more (2009-09-21)
Study Shows Steroid Therapies Following Transplant Can Be Eliminated
A new study by researchers at UC shows that using modern immunosuppressive drugs eliminates the need for steroid therapy as early as seven days following a transplant surgery while still maintaining kidney function view more (2008-10-22)
Researchers use high tech in mould watermark to protect plastic products from piracy
Researchers at WMG at the University of Warwick have devised a high tech way to add Anti-counterfeiting to plastic products as they are created in the moulding process. view more (2008-03-31)
Hepatitis B drug can compromise HIV treatment
Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. view more (2007-06-21)
|
|
| Page
9 of
58 |
1150 Results |
|
|
|
Sort By:
Page Views | Date |
|
